$1.56
-0.06-3.70%
Last update: Dec 16, 2:39 PM
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Comments
Loading...
Inhibikase Therapeutics Short Interest Report
IKTNASDAQ
Inhibikase Therapeutics Stock Short Interest Report | NASDAQ:IKT | Benzinga
Short interest in Inhibikase Therapeutics Inc (NASDAQ:IKT) increased during the last reporting period, rising from 3.09M to 4.14M. This put 5.38% of the company's publicly available shares short.
Based on the recent average volume of 539.25K shares traded per day, it would take 7.68 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
4.14M
Short Interest %
5.38%
Days to Cover
7.68
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| IKT | Inhibikase Therapeutics, Inc. | 11/28/2025 | 12/09/2025 | 5.38% | 76,934,145 | 4,142,443 | 539,248 | 7.68 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 11/14/2025 | 11/25/2025 | 4.01% | 76,934,145 | 3,085,555 | 130,813 | 23.59 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 10/31/2025 | 11/11/2025 | 10.03% | 30,183,735 | 3,027,973 | 95,796 | 31.61 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 10/15/2025 | 10/24/2025 | 10.59% | 30,183,735 | 3,195,011 | 88,456 | 36.12 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 09/30/2025 | 10/09/2025 | 11.52% | 30,183,735 | 3,476,754 | 183,258 | 18.97 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 09/15/2025 | 09/24/2025 | 10.53% | 30,183,735 | 3,178,278 | 100,628 | 31.58 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 08/29/2025 | 09/10/2025 | 11.00% | 30,183,735 | 3,319,737 | 87,443 | 37.96 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 08/15/2025 | 08/26/2025 | 10.91% | 30,183,735 | 3,293,418 | 110,533 | 29.8 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 07/31/2025 | 08/11/2025 | 10.11% | 30,008,640 | 3,033,758 | 123,948 | 24.48 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 07/15/2025 | 07/24/2025 | 10.24% | 30,008,640 | 3,073,788 | 138,063 | 22.26 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 06/30/2025 | 07/10/2025 | 10.87% | 30,008,640 | 3,262,325 | 914,446 | 3.57 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 06/13/2025 | 06/25/2025 | 5.28% | 30,008,640 | 1,585,212 | 97,033 | 16.34 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 05/30/2025 | 06/10/2025 | 5.18% | 30,008,640 | 1,555,196 | 125,673 | 12.37 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 05/15/2025 | 05/27/2025 | 4.60% | 30,008,640 | 1,381,659 | 109,900 | 12.57 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 04/30/2025 | 05/09/2025 | 4.85% | 29,950,615 | 1,454,085 | 114,857 | 12.66 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 04/15/2025 | 04/25/2025 | 2.42% | 58,864,579 | 1,421,862 | 157,159 | 9.05 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 03/31/2025 | 04/09/2025 | 2.24% | 58,864,579 | 1,317,901 | 131,190 | 10.05 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 03/14/2025 | 03/25/2025 | 2.21% | 58,864,579 | 1,303,346 | 117,812 | 11.06 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 02/28/2025 | 03/11/2025 | 2.34% | 58,864,579 | 1,375,069 | 220,970 | 6.22 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 02/14/2025 | 02/26/2025 | 2.14% | 58,864,579 | 1,261,295 | 166,857 | 7.56 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 01/31/2025 | 02/11/2025 | 1.93% | 55,545,182 | 1,070,610 | 225,745 | 4.74 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 01/15/2025 | 01/27/2025 | 1.61% | 55,545,182 | 895,808 | 149,876 | 5.98 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 12/31/2024 | 01/10/2025 | 1.61% | 53,375,313 | 856,885 | 562,072 | 1.52 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 12/13/2024 | 12/24/2024 | 1.26% | 53,375,313 | 672,186 | 293,537 | 2.29 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 11/29/2024 | 12/10/2024 | 0.54% | 53,375,313 | 287,662 | 181,130 | 1.59 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 11/15/2024 | 11/26/2024 | 0.57% | 53,375,313 | 305,663 | 366,733 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 10/31/2024 | 11/11/2024 | 0.29% | 64,942,503 | 187,953 | 371,321 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 10/15/2024 | 10/24/2024 | 0.35% | 64,942,503 | 227,278 | 1,947,874 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 09/30/2024 | 10/09/2024 | 0.67% | 6,632,503 | 44,110 | 19,967 | 2.21 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 09/13/2024 | 09/24/2024 | 0.60% | 6,632,503 | 39,655 | 18,571 | 2.14 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 08/30/2024 | 09/11/2024 | 0.66% | 6,632,503 | 44,041 | 29,226 | 1.51 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 08/15/2024 | 08/26/2024 | 0.83% | 6,632,503 | 54,801 | 14,232 | 3.85 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 07/31/2024 | 08/09/2024 | 0.96% | 6,384,578 | 61,011 | 30,004 | 2.03 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 07/15/2024 | 07/24/2024 | 0.72% | 6,384,578 | 45,795 | 31,515 | 1.45 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 06/28/2024 | 07/10/2024 | 0.83% | 6,384,578 | 52,921 | 24,114 | 2.19 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 06/14/2024 | 06/26/2024 | 1.46% | 6,384,578 | 93,489 | 19,117 | 4.89 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 05/31/2024 | 06/11/2024 | 1.71% | 7,094,070 | 121,292 | 43,460 | 2.79 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 05/15/2024 | 05/24/2024 | 6.12% | 5,646,269 | 345,455 | 94,893 | 3.64 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 04/30/2024 | 05/09/2024 | 2.40% | 5,646,269 | 135,255 | 77,484 | 1.75 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 04/15/2024 | 04/24/2024 | 0.97% | 5,646,269 | 54,568 | 36,317 | 1.5 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 03/28/2024 | 04/09/2024 | 0.36% | 5,669,587 | 20,281 | 55,162 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 03/15/2024 | 03/26/2024 | 0.57% | 5,289,036 | 30,250 | 48,061 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 02/29/2024 | 03/11/2024 | 0.97% | 5,289,036 | 51,343 | 76,410 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 02/15/2024 | 02/27/2024 | 1.61% | 5,289,036 | 85,349 | 272,553 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 01/31/2024 | 02/09/2024 | 1.17% | 5,289,036 | 61,675 | 303,499 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 01/12/2024 | 01/24/2024 | 0.17% | 5,277,036 | 8,780 | 58,127 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 12/29/2023 | 01/10/2024 | 0.18% | 5,277,036 | 9,494 | 89,869 | 1 | Get Alert |
| IKT | Inhibikase Therapeutics, Inc. | 12/15/2023 | 12/27/2023 | 1.05% | 5,277,036 | 55,180 | 247,466 | 1 | Get Alert |
Looking for the most shorted stocks?
People Also Watch
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved